0.13%SPY 128.17 
0.54%WM 4.65 20.10%
Digg
Del.icio.us
Newsvine 
Facebook
Stumbleupon
WOODLANDS, Texas - Biotechnology company Repros Therapeutics Inc. said Friday its first-quarter loss widened on higher spending for clinical development programs.
| RPRX | 9.1 |  0.09 |
The company reported a loss of $6.7 million, or 52 cents per share, compared with a loss of $3.7 million, or 31 cents per share, a year ago. Revenue fell to $269,000 from $318,000.
Analysts polled by Thomson Financial were expecting a loss of 43 cents per share.
Total expenses rose 75 percent to $7 million from $4 million.
Shares of Repros fell 1 cent to $8.82 in after-hours trading after falling 16 cents to close at $8.83 during the regular trading session.
Gold experienced a second day of heavy liquidations, following yesterday oil-led and hawkish Fed-induced rout. Significant losses in the euro wer...
China's largest city and the host of a dozen Olympic soccer matches started...
Swedish specialty steelmaker SSAB reported second-quarter pretax profit above market expectations on Thursday and said the global steel market sh...
Find the most up to date research from leading investment firms to make the most informed investing decisions
Professional Website Design For Corporate - Get a Free Quote Today
Partners  
|
© 2008 The Ibtimes Company. All Rights Reserved. Terms of service | Privacy Policy | Advertising | About Us | Contact Us | Archives
EMAIL
PRINT
RSS
SHARE
